Acceleration of Schwann cells proliferation in vitro using FK506

被引:0
|
作者
Cheng, Biao [1 ]
Chen, Zhen-rong [1 ]
Lin, Jian-ping [1 ]
机构
[1] Department of Orthopedics, Zhanshan Hospital, Fudan University, Shanghai 200032, China
来源
关键词
Growth kinetics - Immunology - Microscopic examination - Neurology;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose: To explore the role and mechanism of FK506 in promoting peripheral nerve regeneration. Methods: The purified Schwann cells from rabbits were divided into three group: 10 μg/L FK506 and the control group. Following 10 days in vitro, the cells from three groups were counted with phase contrast microscope every day to draw proliferation curve respectively. Flow cytometries were carried out in each group after 24 and 72 h respectively. Results: The Schwann cells grew well and a lot of balloons in the shruken fibroblasts cytoplasm were discovered in FK506 groups. The doubling time of control group was 8 days, the 10 and 100 μg/L FK506 group were 6.2 days respectively. The flow cytometry of the three groups showed that Schwann cells in S phase of the two FK506 groups were significanly higher than the control group(P < 0.01). Conclusions: FK506 could promote Schwann cell proliferation and restain the growth of fibroblast in vitro. The double role of immunosuppressive agent FK506 may have broad application prospect in treatment of nerve regeneration.
引用
收藏
页码:208 / 210
相关论文
共 50 条
  • [41] HEPATOTROPHIC EFFECTS OF FK506 IN DOGS
    STARZL, TE
    PORTER, KA
    MAZZAFERRO, V
    TODO, S
    FUNG, J
    FRANCAVILLA, A
    TRANSPLANTATION, 1991, 51 (01) : 67 - 70
  • [42] Effects of FK506 on rat thymic microenvironment in thymocyte maturation, proliferation, and mobilization
    Yamauchi, M
    Tsuchida, M
    Konishi, M
    Takai, K
    Naito, K
    Fukumoto, T
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3600 - 3602
  • [43] 肾移植与FK506
    周吉海,谭季春
    日本医学介绍, 1994, (06) : 269 - 270
  • [44] Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506
    Kotaka, Masayo
    Ye, Hong
    Alag, Reema
    Hu, Guangan
    Bozdech, Zbynek
    Preiser, Peter Rainer
    Yoon, Ho Sup
    Lescar, Julien
    BIOCHEMISTRY, 2008, 47 (22) : 5951 - 5961
  • [45] FK506的肾毒性
    祖强
    姚冰
    于立新
    肾脏病与透析肾移植杂志, 2000, (03) : 251 - 253
  • [46] PANCREATICODUODENAL ALLOTRANSPLANTATION WITH CYCLOSPORINE AND FK506
    SATO, K
    YAMAGISHI, K
    NAKAYAMA, Y
    YOKOTA, K
    UCHIDA, H
    MASAKI, Y
    WATANABE, K
    ASO, K
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1074 - 1075
  • [47] COMPARATIVE STUDIES OF FK506 WITH CYCLOSPORINE
    HEWITT, CW
    BLACK, KS
    TRANSPLANTATION, 1988, 46 (03) : 482 - 483
  • [48] MODEL FOR PREDICTION OF FK506 DOSING
    STEINMULLER, DR
    FITZSIMMONS, WE
    SELF, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 181 - 181
  • [49] INTERACTION BETWEEN FK506 AND ERYTHROMYCIN
    SHAEFFER, MS
    COLLIER, D
    SORRELL, MF
    ANNALS OF PHARMACOTHERAPY, 1994, 28 (02) : 280 - 281
  • [50] CONFORMATION OF AN FK506 ANALOG IN AQUEOUS-SOLUTION IS SIMILAR TO THE FKBP-BOUND CONFORMATION OF FK506
    PETROS, AM
    LULY, JR
    LIANG, H
    FESIK, SW
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (22) : 9920 - 9924